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Breast milk is the natural and optimal food
for infants. In addition to meeting nutri-
tional needs, breast milk provides numerous
immunologic, developmental, psychologic,
economic, and practical advantages (1).
Appropriate feeding practices are essential for
the growth, development, health, nutrition,
and survival of infants and children every-
where (2). It has been postulated that breast-
feeding may also be related to the prevention
of some chronic diseases (e.g., diabetes, obe-
sity) (3,4). Malnutrition among infants and
young children, which remains one of the
most severe global public health problems, is
among the main reasons that the World
Health Organization (WHO) so strongly
supports breast-feeding. Malnutrition is
responsible, directly or indirectly, for fully
60% of the 10.9 million deaths annually
among children under 5 years of age (5). 
To protect breast-feeding from commer-
cial influences, in 1981 WHO adopted the
International Code of Marketing of Breast-
milk Substitutes, which is now being imple-
mented worldwide. Together with the
United Nations Children's Fund (UNICEF),
in 1991 it launched the Baby-friendly
Hospital Initiative so that maternity services
can effectively protect, promote, and support
breast-feeding. In a recent recommendation,
WHO urged its member states to strengthen
activities “to protect, promote and support
exclusive breast-feeding for 6 months as a
global public health recommendation, and to
provide safe and appropriate complementary
foods, with continued breast-feeding for up
to 2 years of age or beyond” (6).
WHO recognizes the growing concern
expressed by scientists, health professionals,
environmentalists, and mothers about the
potential risks posed by the presence of toxi-
cants and infectious agents in breast milk.
WHO programs dealing with chemical
safety, food safety, reproductive health and
research, human immunodeficiency virus
(HIV)/AIDS, nutrition, vaccines and immu-
nization, communicable diseases, and child
and adolescent health and development cur-
rently address these issues. A number of
studies are promoted, guidelines are issued,
and recommendations made on matters
related to potential infectious and toxic risks. 
For example, WHO has prepared guid-
ance on breast-feeding and hepatitis B,
tuberculosis, and HIV transmission, which
are among the main global infectious dis-
ease threats to human health. In addition, a
number of studies have been promoted and
recommendations made concerning selected
environmental pollutants; additional 
information is available on the WHO
Homepage on the Internet (7). A brief
overview follows.
Main Infectious Hazards
In all cases of maternal tuberculosis, mothers
should be treated with an appropriate ther-
apy such as the standard short-course regime
with isoniazid, rifampicin, pyrazinamid, and
ethambutol (which are safe during preg-
nancy and breast-feeding); infants should
not be separated from their mothers, and
breast-feeding should be encouraged (8).
Additional recommendations depend on the
timing of diagnosis. When maternal tuber-
culosis is diagnosed > 2 months before deliv-
ery, and if the sputum smear is negative just
before delivery, the infant should be immu-
nized with BCG (Mycobacterium bovis
Bacillus Calmette-Guerin) as soon as possi-
ble, but preventive chemotherapy should not
be given. However, if the smear is positive,
the infant should receive isoniazid for 6
months and be immunized with BCG after
stopping isoniazid. When maternal tubercu-
losis is diagnosed 2 months before or after
delivery, the infant should receive isoniazid
for 6 months and be immunized with BCG
after stopping isoniazid. When maternal
tuberculosis is diagnosed > 2 months after
delivery, the infant should receive isoniazid
for 6 months and be immunized with BCG
if it was not given at birth (9). 
Hepatitis B virus infection (HBV) is of
major public health importance: there are
>3 50 million chronic carriers, and compli-
cations kill about 1 million people annually.
In highly endemic areas (Southeast Asia and
sub-Saharan Africa), transmission occurs
mainly perinatally or through close contact
between children. In areas of low endemicity
(including Western Europe and North
America), perinatal transmission is less com-
mon (10). Even though the HBV antigen
has been detected in breast milk, there is no
evidence that breast-feeding increases the
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Breast milk is the natural and optimal food for infants. In addition to meeting nutritional needs,
breast milk provides numerous immunologic, developmental, psychologic, economic, and practical
advantages. It is postulated that breast-feeding may also be related to the prevention of some adult
health problems such as diabetes and coronary heart disease. Malnutrition among infants and young
children, which remains one of the most severe global public health problems, is among the main rea-
sons that the World Health Organization (WHO) so strongly supports breast-feeding. However,
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ists, and mothers about the potential risks posed by the presence of toxicants and infectious agents in
breast milk. In this paper we review the main infectious hazards (tuberculosis, hepatitis B, and
human immunodeﬁciency virus) and selected chemical hazards (tobacco, persistent contaminants)
and the activities undertaken by WHO. We conclude that in cases where there is a high degree of
pollution from chemical sources occurring simultaneously in a bacterially contaminated environ-
ment, the choice is not simply between polluted breast milk and risk-free substitutes. Rather,
informed choice is based on assessing the known and unknown risks of artiﬁcial feeding versus the
unknown, but potential, risks of chemical contamination of breast milk. Clearly, the possible toxic-
ity of compounds requires further investigation. Of much greater importance, however, are effective
measures to protect the environment for the entire population by controlling the use of these toxic
products. Current scientiﬁc evidence does not support altering WHO’s global public health recom-
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The risk associated with breast-feeding is
negligible compared to the high risk of expo-
sure to maternal blood and body fluids at
birth. Some concern exists about breast
pathology (cracked or bleeding nipples,
lesions with exudates) that could expose the
infant to infectious doses of HBV.
Immunization can prevent development of
the persistent carrier state in 70–90% of
infants of carrier mothers, and protection
can increase to 85–90% when hepatitis B
immunoglobulin (HBIg) is administered
within 24 hr of birth together with the ﬁrst
dose of vaccine (13). WHO recommends
that all infants receive hepatitis B vaccine as
part of routine childhood immunization, the
first dose to be given within 48 hr of birth
when feasible. Breast-feeding remains the
recommended method of feeding (14). 
It has been estimated that 800,000 chil-
dren younger than 15 years of age were newly
infected in 2001 and that > 90% were due to
mother-to-child transmission (MTCT) (15).
Breast-feeding is associated with an increased
risk of transmission, depending on duration
and other risk factors. In untreated women
who continue breast-feeding after the first
year, the absolute additional risk of transmis-
sion is 10–20% (16,17). This risk must be
balanced against the increased risk of mor-
bidity and mortality due to malnutrition and
diarrheal or other infectious diseases associ-
ated with replacement feeding (2). In addi-
tion, evidence from one study suggests that
exclusive breast-feeding in the ﬁrst 3 months
of life may carry a lower risk of HIV trans-
mission than partial breast-feeding (18). A
three-pronged strategy is recommended by
United Nations agencies for the prevention
of MTCT, which includes the primary pre-
vention of HIV infection among expectant
parents, the prevention of unwanted preg-
nancies in HIV-infected women, and the
prevention of viral transmission with anti-
retroviral regimens, improved obstetric care,
and safer feeding practices. Interventions
such as long and complex courses of zidovu-
dine, cesarean section, and avoidance of
breast-feeding have shown to reduce HIV
transmission from mother to child (19).
However, these measures are not always prac-
tical or safe in resource-limited settings. 
A technical consultation on the prevention
of MTCT convened by WHO/UNICEF/
UNAIDS (Joint United Nations Programme
on HIV/AIDS) in October 2000 (20) made
the following recommendations: only when
replacement feeding is acceptable, feasible,
affordable, sustainable, and safe is avoidance
of all breast-feeding by HIV-infected mothers
recommended; otherwise, exclusive breast-
feeding is recommended during the first
months of life. Mothers should be advised to
discontinue breast-feeding as soon as possible,
taking into consideration local circumstances,
the situation of the mother, and the risks asso-
ciated with replacement feeding. For women
who are HIV negative or whose status is
unknown, exclusive breast-feeding for
6 months, with adequate complementary
feeding and continued breast-feeding there-
after, should be encouraged.
Selected Chemical Hazards
A number of drugs, industrial chemicals,
and environmental contaminants can be pre-
sent in breast milk. Reports on the potential
effects resulting from exposure to toxic sub-
stances in breast milk are found in the med-
ical literature and in statements by scientiﬁc
bodies. For example, antianxiety drugs, anti-
depressants, neuroleptics, nicotine, and sili-
cones have been considered recently by the
American Academy of Pediatrics (21).
Smoking represents a special hazard. It
increases the exposure of mothers and infants
to many chemical compounds, including
pesticide residues and known carcinogens. It
is associated with increased levels of chemical
contaminants in milk as well as reduced
duration of breast-feeding and increased lev-
els of infant distress (“colic”). Women who
smoke should be encouraged to breast-feed
and to eliminate, or at least reduce, cigarette
smoking during pregnancy and lactation.
In the last decade, major concern has
been expressed and there has been some
debate about the presence of environmental
contaminants such as heavy metals (e.g., mer-
cury, lead), pesticides, and persistent organic
pollutants in breast milk and their potential
effects on the health and development of
infants. In some instances, mothers with
known or suspected high levels of contami-
nants in breast milk due to acute or chronic
exposure have been advised to reduce or
interrupt breast-feeding. For example, work-
ers exposed to polychlorinated biphenyls
(PCBs), women consuming high ﬁsh diets in
highly polluted areas, women affected by the
Yusho incident in Japan who ingested rice oil
contaminated with PCBs and furans, and
women affected by the Yu-cheng incident in
Taiwan where cooking oil was contaminated
by PCBs and other polychlorinated com-
pounds, have been advised to reduce or inter-
rupt breast-feeding. Exposure to PCBs and
dioxins has been associated with a greater sus-
ceptibility to infectious diseases in infants
(e.g., middle-ear infections, chickenpox) and
a lower prevalence of allergic reactions.
WHO’s Regional Office for Europe
(WHO/EURO) coordinated two studies
(1987–1989 and 1991–1993), in collaboration
with other organizations, to evaluate the levels
of dioxins in mother’s milk (as a surrogate
measure for body burden). A third study is in
progress. These studies aimed to assess the
possible health risks, especially in infants, and
to control and prevent environmental expo-
sure to those contaminants. The studies
included the consideration of polychlorinated
dibenzo-p-dioxins (PCDDs), polychlorinated
dibenzofurans (PCDFs), dioxin-like PCBs,
and other PCBs. In March 1994, the
Bilthoven Division of WHO/EURO orga-
nized a consultation to review the available
results of the ﬁrst two studies and concluded
that a) levels of PCDDs and PCDFs were not
increasing, although the situation for PCBs
was unclear (noncomparable analytic meth-
ods had been used); b) primary preventive
measures to limit environmental pollution
were the most effective way to limit expo-
sures; and c) breast-feeding should be encour-
aged and promoted due to its multiple
benefits for the overall health and develop-
ment of infants. 
Based on available evidence, the WHO/
EURO consultation noted that infant expo-
sure through breast milk was considerably
less important than exposure in utero. Risk
management should thus aim to limit intake
of contaminated food by the mother rather
than restrict breast-feeding. 
In 1998, the Global Environment
Monitoring System, Food Contamination
Monitoring and Assessment Programme
assessed the risk of selected organochlorine
contaminants in breast milk. Data were
reviewed on breast-milk levels of DDT com-
plex, hexachlorobenzene (HCB), γ-hexa-
chlorocyclohexane (γ-HCH; lindane),
isomeric mixtures of HCH (aldrin and dield-
rin) and PCBs. The reported levels of
residues in human milk of the HCH isomers
aldrin and dieldrin were close to reference
intake values (few reported higher values).
DDT was reported in higher concentrations
in developing countries, and HCB levels
were high in industrialized countries. The
levels of PCBs in breast milk raised greatest
concern. In industrialized countries, concen-
trations exceed the reference intake of
1µ g/kg of body weight; however, levels over
time were stable or only slowly decreased.
The overall conclusions from this assess-
ment were that a) responsible authorities
should consider incorporating into national
risk assessment procedures mechanisms to
assess potential health risks posed by breast-
milk contaminants; b) decision making for
any contemplated intervention should
include a quantitative estimate of risk-based
reference intakes for breast-milk contamina-
tion and take into account the well-estab-
lished benefits of breast-feeding as well as
socioeconomic factors; and c) under most
circumstances authorities can and should
reassure mothers that breast milk is by far
the best food for their babies.
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In cases where there is a high degree of pol-
lution from chemical sources occurring
simultaneously in a bacterially contaminated
environment, the choice is not simply
between polluted breast milk and risk-free
substitutes. Rather, informed choice is based
on assessing the known and unknown risks
of artiﬁcial feeding versus the unknown, but
potential, risks of chemical contamination of
breast milk. Clearly, the possible toxicity of
compounds requires further investigation.
Of much greater importance, however, are
effective measures to protect the environ-
ment for the entire population by control-
ling the use of these toxic products. 
The subtle effects observed in studies are
associated more with transplacental exposure
rather than with exposure through breast-
feeding. Current scientiﬁc evidence does not
support altering WHO’s recommendation
for exclusive breast-feeding for 6 months as a
global public health recommendation and
the provision of safe and appropriate com-
plementary foods, with continued breast-
feeding for up to 2 years of age or beyond.
REFERENCES AND NOTES
1. American Academy of Pediatrics policy statement.
Breastfeeding and the use of human milk. Pediatrics
100(6):1035–1039 (1997).
2. WHO Collaborative Study Team on the Role of
Breastfeeding on the Prevention of Infant Mortality.
Effect of breastfeeding on infant and child mortality due
to infectious diseases in less developed countries: a
pooled analysis. Lancet 355:451–455 (2000).
3. Deckelbaum RJ, Williams CL. Childhood obesity: the
health issue. Obes Res 9(suppl 4):239S–243S (2001).
4. Martorell R, Stein AD, Schroeder DG. Early nutrition and
later adiposity. J Nutr 131(3):874S–880S (2001).
5. World Health Assembly. Childhood Nutrition and
Progress in Implementing the International Code of
Marketing of Breast-milk Substitutes. Available:
http://www.who.int/gb/EB_WHA/PDF/WHA55/ea5514.pdf
[cited 4 April 2002].
6. World Health Assembly. Infant and Young Child Nutrition.
Resolution WHA54.2. Available: http://www.who.int/
gb/EB_WHA/PDF/WHA54/ea54r2.pdf [cited 28 March
2002].
7. World Health Organization Homepage. Available:
http://www.who.int/home-page/ [cited 27 March 2002]. 
8. Crofton J, Horne N, Miller F. Clinical tuberculosis,
London:Macmillan Education Ltd, 1992.
9. Child and Adolescent Health and Development.
Breastfeeding and Maternal Tuberculosis. Update No. 23.
Available: http://www.who.int/child-adolescent-health/
New_Publications/NUTRITION/Breastfeeding_Tub.pdf
[cited 28 March 2002]. 
10. Protection against viral hepatitis recommendations of
the Immunization Practices Advisory Committee (ACIP).
MMWR Recomm Rep 39(RR 2):1–26 (1990). 
11. Beasley PR, Chiao I-S, Steves CE, Meng H-C. Evidence
against breastfeeding as a mechanism for vertical trans-
mission of hepatitis B. Lancet ii:740–741 (1975).
12. de Martino M, Appendino C, Resti M, Rossi ME, Muccioli
AT, Vierucci A. Should hepatitis B surface antigen positive
mothers breast feed? Arch Dis Child 60(10):972–974 (1985).
13. Maynard JE, Kane MA, Hadler SC. Global control of
hepatitis B through vaccination: role of hepatitis B vac-
cine in the expanded programme on immunization. Rev
Infect Dis 11(S3):S574–S578 (1989). 
14. Child and Adolescent Health and Development.
Hepatitis B and Breastfeeding. Update No 22. Available:
http://www.who.int/child-adolescent-health/
New_Publications/NUTRITION/updt-22.htm [cited 28
March 2002]. 
15. Joint United Nations Programme on HIV/AIDS. AIDS
Epidemic Update—December 2001. Available: http://
www.unaids.org/epidemic_update/report_dec01/
index.html [cited 28 March 2002].
16. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba
J, Hoff E, Alnwick DJ, Rogers M, Shaffer N. Prevention of
mother-to-child HIV transmission in resource-poor coun-
tries: translating research into policy and practice.
JAMA 283:1175–1182 (2000). 
17. Nduati R, John G, Mbori-Ngacha D, Richardson B,
Overbaugh J, Mwatha A, Ndinya-Achola J, Bwayo J,
Onyango FE, Hughes J, Kreiss J. Effect of breastfeeding
and formula feeding on transmission of HIV-1: a random-
ized clinical trial. JAMA 283:1167–1174 (2000). 
18. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM.
Influence of infant-feeding patterns on early mother-to-
child transmission of HIV-1 in Durban, South Africa: a
prospective cohort study. South African Vitamin A Study
Group. Lancet 354: 471–476 (1999).
19. Joint United Nations Programme on HIV/AIDS. Mother to
Child Transmission. Available: http://www.unaids.org/
publications/documents/mtct/index.html [cited 28 March
2002].
20. WHO Technical Consultation on behalf of the
UNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team
on Mother-to-Child Transmission of HIV. New data on
the prevention of mother-to-child transmission of HIV
and their policy implications – Conclusions and recom-
mendations. Geneva:World Health Organization, 2000.
21. The transfer of drugs and other chemicals into human
milk. Pediatrics 108(3):776–789 (2001). Available: http://
www.aap.org/policy/0063.html [cited 28 March 2002].
Mini-Monograph • Infectious and toxic hazards in breast milk
Environmental Health Perspectives • VOLUME 110 | NUMBER 6 | June 2002 A 351